Fidelity Investments
NVIV

Fidelity Investments’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Fidelity Investments’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-73
Closed -$99 – 5673
2023
Q2 		$99 Buy
+73
New +$93 ﹤0.01% 4960
2021
Q3 		– Hold
0
– – – 5383
2021
Q2 		– Hold
0
– – – 5222

Other funds holding NVIV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Fidelity Investments's NVIV Position: Q3 2023 in Review

Fidelity Investments sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2023, closing a stake of 73 shares — an estimated $99 sold.

Fidelity Investments first reported a position in NVIV in Q2 2023 and held it in 1 quarter. The position peaked at $99 in Q2 2023. 15 funds tracked by Wall St. Rank hold NVIV as of Q3 2023.

  • Fidelity Investments reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2023 after selling out during the quarter.
  • Fidelity Investments sold 73 InVivo Therapeutics Holdings Corp shares in Q3 2023, an estimated $99.
  • Fidelity Investments first reported a position in InVivo Therapeutics Holdings Corp in Q2 2023 and held it in 1 quarter.
  • Fidelity Investments's InVivo Therapeutics Holdings Corp position peaked at $99 in Q2 2023.
  • 15 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.